Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Paediatric Respiratory Reviews
|
February 9, 2005
Development of medicines for children in Europe: ethical implications
Agnès Saint Raymond, Daniel Brasseur
Paediatric Drugs
|
January 9, 2009
The European paediatric initiative: 1 year of experience
Agnès Saint-Raymond, Nathalie Seigneuret
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
What to Know About Medicines With New Active Ingredients Approved in FY 2016 / 2016 in Japan and EU: A Brief Comparison of New Medicines Approved in Japan and the EU in 2016
Hideyuki Kondo, Agnès Saint-Raymond, Naoyuki Yasuda
Expert Review of Clinical Pharmacology
|
March 24, 2015
White spots in pharmaceutical pipelines-EMA identifies potential areas of unmet medical needs
Marisa Papaluca, Martina Greco, Enrico Tognana, et al.
Archives of Disease in Childhood
|
November 7, 2015
Usage of unpublished paediatric data
Agnès Saint-Raymond, Benjamin Pelle, Cosimo Zaccaria, et al.
Expert Review of Clinical Pharmacology
|
February 8, 2022
WHO collaborative registration procedure using stringent regulatory authorities' medicine evaluation: reliance in action?
Alexandra Vaz, Mariana Roldão Santos, Luther Gwaza, et al.
Trials
|
November 21, 2018
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency
Olivier Collignon, Franz Koenig, Armin Koch, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
November 16, 2010
Guidance for clinical trials for children and adolescents with chronic hepatitis C
Stefan Wirth, Deirdre Kelly, Etienne Sokal, et al.
Transgenic Research
|
July 22, 2017
Fostering responsible research with genome editing technologies: a European perspective
Hervé Chneiweiss, François Hirsch, Lluis Montoliu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Paediatric Respiratory Reviews
|
February 9, 2005
Development of medicines for children in Europe: ethical implications
Agnès Saint Raymond, Daniel Brasseur
Paediatric Drugs
|
January 9, 2009
The European paediatric initiative: 1 year of experience
Agnès Saint-Raymond, Nathalie Seigneuret
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
What to Know About Medicines With New Active Ingredients Approved in FY 2016 / 2016 in Japan and EU: A Brief Comparison of New Medicines Approved in Japan and the EU in 2016
Hideyuki Kondo, Agnès Saint-Raymond, Naoyuki Yasuda
Expert Review of Clinical Pharmacology
|
March 24, 2015
White spots in pharmaceutical pipelines-EMA identifies potential areas of unmet medical needs
Marisa Papaluca, Martina Greco, Enrico Tognana, et al.
Archives of Disease in Childhood
|
November 7, 2015
Usage of unpublished paediatric data
Agnès Saint-Raymond, Benjamin Pelle, Cosimo Zaccaria, et al.
Expert Review of Clinical Pharmacology
|
February 8, 2022
WHO collaborative registration procedure using stringent regulatory authorities' medicine evaluation: reliance in action?
Alexandra Vaz, Mariana Roldão Santos, Luther Gwaza, et al.
Trials
|
November 21, 2018
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency
Olivier Collignon, Franz Koenig, Armin Koch, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
November 16, 2010
Guidance for clinical trials for children and adolescents with chronic hepatitis C
Stefan Wirth, Deirdre Kelly, Etienne Sokal, et al.
Transgenic Research
|
July 22, 2017
Fostering responsible research with genome editing technologies: a European perspective
Hervé Chneiweiss, François Hirsch, Lluis Montoliu, et al.
Page
of 1